General Information of Drug (ID: DMJ13KI)

Drug Name
Terconazole Drug Info
Synonyms
Fungistat; Terazol; Terconazol; Terconazolum; Tercospor; Triaconazole; Zazole; R 42470; Terazol 3; Terazol 7; Terazol 73; Tetrazol 3; Tetrazol 7; Gyno-Terazol; R 42,470; R-42470; Terazol 3 (TN); Terazol 7 & 3; Terazol Cream & Suppositories; Terconazol [INN-Spanish]; Terconazolum [INN-Latin]; Terconazole (USAN/INN); Terconazole [USAN:INN:BAN]; Cis-1-(p-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-isopropylpiperazine; Piperazine, 1-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-, rel-(2R,4S); 1-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(1-methylethyl)piperazine; 1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine; 1-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine; 1-[4-[[(4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine; 1-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine
Indication
Disease Entry ICD 11 Status REF
Candidiasis 1F23 Approved [1]
Therapeutic Class
Antifungal Agents
Cross-matching ID
PubChem CID
441383
ChEBI ID
CHEBI:82980
CAS Number
67915-31-5
TTD ID
D01AQT
ACDINA ID
D01477

Full List of Drug Formulations Containing This Drug

Terconazole 0.4% cream
Company Formulation ID FDA Description
Janssen Pharms F23916 Butylated Hydroxyanisole; Cetyl Alcohol; Isopropyl Myristate; Polysorbate 60; Polysorbate 80; Propylene Glycol; Stearyl Alcohol; Purified Water
------------------------------------------------------------------------------------
Terconazole 80 mg Vaginal Suppository
Company Formulation ID FDA Description
Janssen Pharms F23917 Triglycerides Derived From Coconut; Palm Kernel Oil; Butylated Hydroxyanisole
------------------------------------------------------------------------------------

References

1 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 021735.